INMInMed Pharmaceuticals Inc.
Health Care
Operating Expenses revised down 12.2% for FY 2025
This is the 5th largest revision in INM's history.
Operating Expenses·FY 2025
Major restatement$8.5M▼ 12.2%
was$9.7M
Revised down in a S-4/A.
Verify against SEC filingsShow
As reported$9.7M
Accepted 2025-09-230001213900-25-090210
Restated$8.5M
Accepted 2026-09-300001193125-26-407792
OperatingExpenses · reported 5 times · point-in-time, survivorship-free. Every figure traces to its filing above.
Track this the moment it happens
Get a signal the next time INM — or any company on your watchlist — restates a number. Every signal lands with the diff and its source filing.